tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shanghai Junshi Biosciences Strengthens Governance with Compliance Committee Guidelines

Story Highlights
Shanghai Junshi Biosciences Strengthens Governance with Compliance Committee Guidelines

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) is now available.

Shanghai Junshi Biosciences Co., Ltd. has released the terms of reference for its Compliance Committee of the Board of Directors. This document outlines the general provisions, composition, terms of reference, rules of procedure, and supplementary provisions for the committee, which plays a crucial role in ensuring the company’s adherence to regulatory and ethical standards. The establishment of these guidelines is expected to enhance the company’s governance framework and reinforce its commitment to compliance, potentially impacting its operational integrity and stakeholder trust.

The most recent analyst rating on (HK:1877) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock, see the HK:1877 Stock Forecast page.

More about Shanghai Junshi Biosciences Co., Ltd. Class H

Average Trading Volume: 13,773,473

Technical Sentiment Signal: Buy

Current Market Cap: HK$48.06B

Learn more about 1877 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1